Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM

6 Episodes

Reverse

Wrap Up

2024-11-1901:43

Long-Term Safety and Efficacy of Zilucoplan in Generalized Myasthenia Gravis 120-Week Interim Analysis of RAISE-XT

2024-11-1902:53

Author: Howard, JF, et al.Overview Provided by Nicolas Silvestri, MD

Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study

2024-11-1903:26

Author: Strober J, et al.Overview Provided by Nicolas Silvestri, MD

Concomitant Corticosteroid Use with Ravulizumab in Adults with Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Phase 3 CHAMPION-MG Open-Label Extension Final Results

2024-11-1903:25

Author: Nicolle M, et al.Overview Provided by Nicolas Silvestri, MD

Cyclic and Every-Other-Week Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis Part A of ADAPT NXT

2024-11-1903:14

Author: Habib AA, et alOverview Provided by Nicolas Silvestri, MD

Introduction

2024-11-1902:12

#box-pro-ellipsis-176418589294438{-webkit-line-clamp:2;}Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM

Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM